Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
89 hedge funds and large institutions have $170M invested in Tetraphase Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 14 closing their positions.
218% more call options, than puts
Call options by funds: $1.71M | Put options by funds: $537K
134% more capital invested
Capital invested by funds: $72.6M → $170M (+$97.4M)
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
2% less funds holding
Funds holding: 91 → 89 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.9M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.55M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.29M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.68M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.31M |
| 3 |
Renaissance Technologies
New York
|
-$1.18M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$970K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$725K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
101
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$1K | -10 | Closed |
|
|
CTC
102
Central Trust Company
Jefferson City,
Missouri
| – | +$112 | +1 | New |
|
103
Creative Planning
Overland Park,
Kansas
| – | +$112 | +1 | New |
|
TTPH Hedge Fund Activity: Q1 2017 in Review
89 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2017, worth a combined $170M — up 134% from $72.6M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TTPH positions and 14 closed out — a net gain of 2 holders — while 32 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $12.9M. The largest seller was Wellington Management Group, cutting an estimated $4.68M.
- 89 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2017, down from 91 in Q4 2016.
- Funds reported $170M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2017, up 134% quarter-over-quarter.
- 16 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2017 and 14 closed out, a net change of +2 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $12.9M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2017 was Wellington Management Group, an estimated $4.68M sold.
Based on aggregated 13F filings for Q1 2017.